DekaBank Deutsche Girozentrale - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 89 filers reported holding STOKE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$257,000
+97.7%
20,000
+100.0%
0.00%
Q2 2022$130,000
-41.4%
10,0000.0%0.00%
-100.0%
Q1 2022$222,000
+8.3%
10,000
+9.9%
0.00%
Q4 2021$205,000
-9.7%
9,100
+2.2%
0.00%
-100.0%
Q3 2021$227,000
-22.0%
8,9000.0%0.00%0.0%
Q2 2021$291,000
-11.3%
8,9000.0%0.00%0.0%
Q1 2021$328,000
-37.3%
8,9000.0%0.00%
-50.0%
Q4 2020$523,000
+72.6%
8,9000.0%0.00%
+100.0%
Q3 2020$303,0008,9000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,355,466$69,401,0004.13%
Cormorant Asset Management, LP 1,788,394$38,433,0002.34%
RA Capital Management 1,119,963$24,068,0001.43%
SPHERA FUNDS MANAGEMENT LTD. 346,380$7,384,0001.14%
Redmile Group, LLC 1,017,478$21,866,0000.73%
GILDER GAGNON HOWE & CO LLC 1,876,191$40,319,0000.46%
Perceptive Advisors 671,978$14,440,0000.39%
Casdin Capital, LLC 130,000$2,793,700,0000.29%
OXFORD ASSET MANAGEMENT LLP 116,196$2,497,0000.06%
Granite Point Capital Management, L.P. 17,000$365,0000.06%
View complete list of STOKE THERAPEUTICS INC shareholders